Infrapopliteal lesion morphology in patients with critical limb ischemia: Implications for the development of anti-restenosis technologies

Journal of Endovascular Therapy

Volumn 20, Issue 2, 2013, Pages 149-156

  Baumann, Frederic ^a,b   Engelberger, Rolf P ^a   Willenberg, Torsten ^a   Do, Dai Do ^a   Kalka, Christoph ^c   Baumgartner, Iris ^a   Diehm, Nicolas ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c Division of Cardiovascular Medicine   (Germany)

Author keywords

Critical limb ischemia; Drug eluting balloons; Drug eluting stents; Infrapopliteal arterial disease; Lesion morphology

Indexed keywords

AGED; ARTERY CALCIFICATION; ARTICLE; BLOOD VESSEL DIAMETER; CLINICAL TRIAL; CRITICAL LIMB ISCHEMIA; ENDOVASCULAR SURGERY; FEMALE; HUMAN; LEG ANGIOGRAPHY; LEG REVASCULARIZATION; LIMB INJURY; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; ANGIOPLASTY; CONSTRICTION, PATHOLOGIC; CRITICAL ILLNESS; FEMALE; HUMANS; ISCHEMIA; LOWER EXTREMITY; MALE; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROSPECTIVE STUDIES; RECURRENCE; SEVERITY OF ILLNESS INDEX; TERTIARY CARE CENTERS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR CALCIFICATION;

EID: 84877739908     PISSN: 15266028     EISSN: 15451550     Source Type: Journal    
DOI: 10.1583/1545-1550-20.2.149     Document Type: Article

References (30)

1. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33 Suppl 1:S1-75.
2. Lepantalo M, Matzke S. Outcome of unreconstructed chronic critical leg ischaemia. Eur J Vasc Endovasc Surg. 1996;11:153-157. (Pubitemid 26120467)
3. Beard JD. Which is the best revascularization for critical limb ischemia: endovascular or open surgery? J Vasc Surg. 2008;48(6 Suppl):11S-6S.
4. Norgren L, Hiatt WR, Dormandy JA, et al. Inter- Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45 Suppl S:S5-67.
5. Adam DJ, Beard JD, Cleveland T, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366:1925-1934. (Pubitemid 41713982)
6. Conrad MF, Crawford RS, Hackney LA, et al. Endovascular management of patients with critical limb ischemia. J Vasc Surg. 2011;53:1020-1025.
7. Schmidt A, Ulrich M, Winkler B, et al. Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease. Catheter Cardiovasc Interv. 2010;76:1047-1054.
8. Baumann F, Willenberg T, Do DD, et al. Endovascular revascularization of below-the-knee arteries: prospective short-term angiographic and clinical follow-up. J Vasc Interv Radiol . 2011;22:1665-1673.
9. Balzer JO, Khan V, Thalhammer A, et al. Below the knee PTA in critical limb ischemia results after 12 months: single center experience. Eur J Radiol. 2010;75:37-42.
10. Bosiers M, Scheinert D, Peeters P, et al. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. J Vasc Surg. 2012;55:390-398.
11. Rastan A, Tepe G, Krankenberg H, et al. Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trial. Eur Heart J. 2011;32:2274-2281.
12. Scheinert D. The Achilles study - A prospective, randomized, multicenter comparison of balloon angioplasty and the CYPHER SELECT plus coronary and infrapopliteal stent in the treatment of subjects with ischemic infrapopliteal arterial disease. Presented at LINC 2011; January 19, 2011, Leipzig, Germany. Available at: http://www.leipzig-interventional-course.com/index.php?option=com- docman&task=doc-download&gid=799. Last access January 28, 2013.
13. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Int Bioethique. 2004;15:124-129.
14. Second European Consensus Document on chronic critical leg ischemia. Eur J Vasc Surg. 1992;6 Suppl A:1-32.
15. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31:S1-S296.
16. Diehm N, Pattynama PM, Jaff MR, et al. Clinical endpoints in peripheral endovascular revascularization trials: a case for standardized definitions. Eur J Vasc Endovasc Surg. 2008;36:409-419.
17. Ferraresi R, Centola M, Ferlini M, et al. Long-term outcomes after angioplasty of isolated, below-the-knee arteries in diabetic patients with critical limb ischaemia. Eur J Vasc Endovasc Surg. 2009;37:336-342.
18. Soder HK, Manninen HI, Jaakkola P, et al. Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia: angiographic and clinical results. J Vasc Interv Radiol. 2000;11:1021-1031.
19. Rastan A, Brechtel K, Krankenberg H, et al. Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial. J Am Coll Cardiol. 2012;60:587-591.
20. Romiti M, Albers M, Brochado-Neto FC, et al. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg. 2008;47:975-981.
21. Graziani L, Silvestro A, Bertone V, et al. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur J Vasc Endovasc Surg. 2007;33:453-460. (Pubitemid 46349954)
22. Schmidt A, Piorkowski M, Werner M, et al. First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. J Am Coll Cardiol. 2011;58:1105-1109.
23. Rastan A, Schwarzwalder U, Noory E, et al. Primary use of sirolimus-eluting stents in the infrapopliteal arteries. J Endovasc Ther. 2010;17:480-487.
24. Commeau P, Barragan P, Roquebert PO. Sirolimus for below the knee lesions: mid-term results of SiroBTK study. Catheter Cardiovasc Interv. 2006;68:793-798. (Pubitemid 44721107)
25. Scheinert D, Ulrich M, Scheinert S, et al. Comparison of sirolimus-eluting vs. bare-metal stents for the treatment of infrapopliteal obstructions. EuroIntervention. 2006;2:169-174.
26. Werner M, Schmidt A, Freyer M, et al. Sirolimus-eluting stents for the treatment of infrapopliteal arteries in chronic limb ischemia: long-term clinical and angiographic follow-up. J Endovasc Ther. 2012;19:12-19.
27. Feiring AJ, Krahn M, Nelson L, et al. Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: the PaRADISE (PReventing Amputations using Drug eluting StEnts) trial. J Am Coll Cardiol. 2010;55:1580-1589.
28. Karnabatidis D, Spiliopoulos S, Diamantopoulos A, et al. Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia. J Endovasc Ther. 2011;18:1-12.
29. Katsanos K, Karnabatidis D, Diamantopoulos A, et al. Cost-effectiveness analysis of infrapopliteal drug-eluting stents. Cardiovasc Intervent Radiol. 2013;36:90-97.
30. Schmidt A, Ulrich M, Winkler B, et al. Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease. Catheter Cardiovasc Interv. 2010;76:1047-1054.